Backed by clinical studies, such as those by Leyden et al
Researchers are finding more indications every day for patients to take these weight loss medications
2016 Novo Nordisk All rights reserved
Clin Liver Dis 12(4):769790 Volpe S, Lisco G, Fanelli M, Racaniello D, Colaianni V, Triggiani D, Donghia R, Crudele L, Rinaldi R, Sabb C (2022) Once-weekly subcutaneous semaglutide improves fatty liver disease in patients with type 2 diabetes: a 52-week prospective real-life study
The D-isomer has pharmacologic effects but does not participate in lipid metabolism
Supplementing with high-dose iodine or selenium isnt recommended unless your doctor has identified a specific deficiency